These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 23471323

  • 1. [Retinal impairment in young individuals with sickle cell anemia (hemoglobin SS disease) in university hospital in Northeastern of Brazil].
    Santos AM, Faro GB, Amaral MV, Mendonça Cde Q, Leal BC, Cipolotti R.
    Arq Bras Oftalmol; 2012 Oct; 75(5):313-5. PubMed ID: 23471323
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Role of OCT-angiography in the management of sickle cell retinopathy].
    Croisé F, Le Lez ML, Pisella PJ.
    J Fr Ophtalmol; 2020 Jan; 43(1):7-17. PubMed ID: 31831271
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. When should children and young adults with sickle cell disease be referred for eye assessment?
    Babalola OE, Wambebe CO.
    Afr J Med Med Sci; 2001 Dec; 30(4):261-3. PubMed ID: 14510100
    [Abstract] [Full Text] [Related]

  • 9. Proliferative sickle cell retinopathy under age 20: a review.
    Kimmel AS, Magargal LE, Maizel R, Robb-Doyle E.
    Ophthalmic Surg; 1987 Feb; 18(2):126-8. PubMed ID: 2437512
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Ocular and electroretinographic changes in sickle cell disease].
    David RC, Moraes Júnior HV, Rodrigues MP.
    Arq Bras Oftalmol; 2011 Feb; 74(3):190-4. PubMed ID: 21915446
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between peripheral vascular closure and proliferative retinopathy in sickle cell disease.
    van Meurs JC.
    Graefes Arch Clin Exp Ophthalmol; 1991 Feb; 229(6):543-8. PubMed ID: 1765296
    [Abstract] [Full Text] [Related]

  • 15. Peripheral multifield scanning fluorescein angiography for the evaluation of proliferative sickle cell retinopathy.
    Stephens RF, Magargal LE.
    Ophthalmic Surg; 1987 Apr; 18(4):291-4. PubMed ID: 2438617
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Macular Vascular Abnormalities Identified by Optical Coherence Tomography Angiography in Sickle Cell Disease.
    Han IC, Tadarati M, Pacheco KD, Scott AW.
    Am J Ophthalmol; 2017 May; 177():90-99. PubMed ID: 28212878
    [Abstract] [Full Text] [Related]

  • 17. UTILITY OF ULTRA-WIDEFIELD RETINAL IMAGING FOR THE STAGING AND MANAGEMENT OF SICKLE CELL RETINOPATHY.
    Han IC, Zhang AY, Liu TYA, Linz MO, Scott AW.
    Retina; 2019 May; 39(5):836-843. PubMed ID: 29384996
    [Abstract] [Full Text] [Related]

  • 18. Sickle cell retinopathy and other chronic complications of sickle cell anemia: A clinical study of 84 Sub-Saharan African cases (Cameroon).
    Bilong Y, Dubert M, Koki G, Noubiap JJ, Pangetna HN, Menet A, Chelo D, Offredo L, Jacob S, Belinga S, Yanda ANA, Kingue S, Jouven X, Ranque B, Bella LA.
    J Fr Ophtalmol; 2018 Jan; 41(1):50-56. PubMed ID: 29295792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.